Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse

Autor: Maja Malnar, Angela Bachi, Helena H. Chowdhury, Anemari Horvat, Patrizia D’Adamo, Antonia Gurgone, Saša Trkov Bobnar, Marko Muhič, Lorenzo Piemonti, Maria Lidia Mignogna, Michela Masetti, Jelena Velebit, Veronica Bianchi, Robert Zorec, Matjaž Stenovec, Alessia Mercalli, Katja Fink, Sara Belloli, Stefano Taverna, Maja Potokar, Marko Kreft, Rosa Maria Moresco, Nina Vardjan, Maddalena Ripamonti, Umberto Restuccia
Přispěvatelé: D'Adamo, Patrizia, Horvat, Anemari, Gurgone, Antonia, Mignogna, Maria Lidia, Bianchi, Veronica, Masetti, Michela, Ripamonti, Maddalena, Taverna, Stefano, Velebit, Jelena, Malnar, Maja, Muhič, Marko, Fink, Katja, Bachi, Angela, Restuccia, Umberto, Belloli, Sara, Moresco, Rosa Maria, Mercalli, Alessia, Piemonti, Lorenzo, Potokar, Maja, Bobnar, Saša Trkov, Kreft, Marko, Chowdhury, Helena H, Stenovec, Matjaž, Vardjan, Nina, Zorec, R, D'Adamo, P, Horvat, A, Gurgone, A, Mignogna, M, Bianchi, V, Masetti, M, Ripamonti, M, Taverna, S, Velebit, J, Malnar, M, Muhic, M, Fink, K, Bachi, A, Restuccia, U, Belloli, S, Moresco, R, Mercalli, A, Piemonti, L, Potokar, M, Bobnar, S, Kreft, M, Chowdhury, H, Stenovec, M, Vardjan, N
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
CTX
context memory

Male
Endocrinology
Diabetes and Metabolism

Glucose uptake
Intellectual disability
FRET
Förster Resonance Energy Transfer

SV
synaptic vesicle

XLID
X-linked intellectual disability

Mice
0302 clinical medicine
Endocrinology
Basic Science
GDI1 knockout mice
Aerobic glycolysis
Astrocytes
cAMP
Glycolysis
Gdi1 KO
full knockout of Gdi1

Cells
Cultured

Guanine Nucleotide Dissociation Inhibitors
NA
noradrenaline

Mice
Knockout

Cultured
3-Cl-5-OH-BA
3-chloro-5-hydroxybenzoic acid

Animals
Brain
Deoxyglucose
Down-Regulation
Glucose
Intellectual Disability
Maze Learning
Memory
Memory Disorders
[18F]-FDG
[18F]-fluoro-2-deoxy-d-glucose

Aerobic glycolysi
cAMP
cyclic adenosine monophosphate

GlastGdi1flox/Y
GLAST:CreERT2+/Gdi1lox/Y inducible astrocyte-specific Gdi1 KO male mice

medicine.anatomical_structure
intellectual disability
Knockout mouse
Astrocyte
Gdi1 WT
wild type

medicine.medical_specialty
Cells
Knockout
030209 endocrinology & metabolism
Biology
2-DG
2-deoxy-d-glucose

sEPSCs
spontaneous excitatory postsynaptic currents

CNS
central nervous system

SEM
standard error of the mean

03 medical and health sciences
αGDI
α guanosine dissociation inhibitor protein coded by GDI1 gene

CFP
cyan fluorescent protein

Downregulation and upregulation
Internal medicine
medicine
aerobic glycolysis
GlastGdi1X/Y
male mice (Gdi1X/Y) carrying the GLAST:CreERT2 transgene

GLUT1
d-glucose transporter

Wild type
astrocytes
GFAP
glial fibrillary acidic protein

PSD
postsynaptic density

GDI1
guanosine dissociation inhibitor 1 gene

YFP
yellow fluorescent protein

030104 developmental biology
GPCR
G-protein coupled receptor

Anaerobic glycolysis
GPR81
G-protein receptor 81

CS
conditional stimulus
tone

PKA
protein kinase A

MCTs
monocarboxylate transporters

Homeostasis
Zdroj: Metabolism
Metabolism, clinical and experimental
116 (2021): 154463. doi:10.1016/j.metabol.2020.154463
info:cnr-pdr/source/autori:D'Adamo P.; Horvat A.; Gurgone A.; Mignogna M.L.; Bianchi V.; Masetti M.; Ripamonti M.; Taverna S.; Velebit J.; Malnar M.; Muhic M.; Fink K.; Bachi A.; Restuccia U.; Belloli S.; Moresco R.M.; Mercalli A.; Piemonti L.; Potokar M.; Bobnar S.T.; Kreft M.; Chowdhury H.H.; Stenovec M.; Vardjan N.; Zorec R./titolo:Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse/doi:10.1016%2Fj.metabol.2020.154463/rivista:Metabolism, clinical and experimental (Print)/anno:2021/pagina_da:154463/pagina_a:/intervallo_pagine:154463/volume:116
ISSN: 1532-8600
0026-0495
DOI: 10.1016/j.metabol.2020.154463
Popis: Objectives GDI1 gene encodes for αGDI, a protein controlling the cycling of small GTPases, reputed to orchestrate vesicle trafficking. Mutations in human GDI1 are responsible for intellectual disability (ID). In mice with ablated Gdi1, a model of ID, impaired working and associative short-term memory was recorded. This cognitive phenotype worsens if the deletion of αGDI expression is restricted to neurons. However, whether astrocytes, key homeostasis providing neuroglial cells, supporting neurons via aerobic glycolysis, contribute to this cognitive impairment is unclear. Methods We carried out proteomic analysis and monitored [18F]-fluoro-2-deoxy-d-glucose uptake into brain slices of Gdi1 knockout and wild type control mice. d-Glucose utilization at single astrocyte level was measured by the Förster Resonance Energy Transfer (FRET)-based measurements of cytosolic cyclic AMP, d-glucose and L-lactate, evoked by agonists selective for noradrenaline and L-lactate receptors. To test the role of astrocyte-resident processes in disease phenotype, we generated an inducible Gdi1 knockout mouse carrying the Gdi1 deletion only in adult astrocytes and conducted behavioural tests. Results Proteomic analysis revealed significant changes in astrocyte-resident glycolytic enzymes. Imaging [18F]-fluoro-2-deoxy-d-glucose revealed an increased d-glucose uptake in Gdi1 knockout tissue versus wild type control mice, consistent with the facilitated d-glucose uptake determined by FRET measurements. In mice with Gdi1 deletion restricted to astrocytes, a selective and significant impairment in working memory was recorded, which was rescued by inhibiting glycolysis by 2-deoxy-d-glucose injection. Conclusions These results reveal a new astrocyte-based mechanism in neurodevelopmental disorders and open a novel therapeutic opportunity of targeting aerobic glycolysis, advocating a change in clinical practice.
Highlights • Mutations in human Gdi1, encoding αGDI, a protein controlling vesicle traffic, are responsible for Intellectual Disability. • Gdi1 knockout revealed significant changes in astrocyte-resident glycolytic enzymes and facilitated D-glucose utilization. • Astrocyte-selective Gdi1 deletion impairs working memory, which can be rescued by administration of 2-deoxy-D-glucose. • Astrocyte-based glycolysis is a new target to treat Intellectual Disability.
Databáze: OpenAIRE